|
|
UCB Showcases the Depth of its Immunology Research and Commitment to Patientsat EULAR 2019Three oral presentations on novel investigational molecule bimekizumab to show potential for improving disease activity and quality of life outcomes in patients with ankylosing spondylitis, and musculoskeletal and skin outcomes over 48 weeks in those with psoriatic arthritisMultiple presentations will... See more |
|
|
|
| |
|
| |
|
|
communiqué de presse Information réglementée
06 juin 2019
L'Assemblée Générale Extraordinaire réunie le 21 mai 2019 a approuvé le remboursement de prime d'émission assimilée à du capital libéré d'un montant de 0,12 euro par action.
Ce remboursement interviendra pour toute action existante à la date de détachement du coupon.
Conformément à l'article 613 du Code... See more |
|
|
|
| |
|
| |
|
|
PRESS RELEASE:
REPURCHASE OF OWN SHARES IN THE CONTEXT OF THE LIQUIDITY CONTRACT
REGULATED INFORMATION
Wednesday 5 June 2019 – 6:00 pm
Repurchase of own shares in the context of... See more |
|
|
|
| |
|
| |
|
|
Antwerpen BE, 4 June 2019, 7:00 PM CET
DWS Fund to acquire Hansea, a leading Belgian public transport
infrastructure operator, from Cube Infrastructure Fund and Gimv
Cube Infrastructure Fund Cube and Gimv today announce the sale of Hansea to a fund managed
by DWS “DWS”, a global infrastructure manager. With the support of its investors, the company
... | |
Search :
